MDCX vs RPTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 02, 2026

MDCX

62.5
AI Score
VS
MDCX Wins

RPTX

47.7
AI Score

Investment Advisor Scores

MDCX

63score
Recommendation
STRONG BUY

RPTX

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MDCX RPTX Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -76.7% MDCX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 62.5/100 47.7/100 MDCX
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD MDCX

Relative Price Performance (Last 90 Days)

MDCX 1M: -16.5% · 3M: -24.9% RPTX 1M: +3.3% · 3M: +37.3%

Current Technical Phase

MDCX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.8%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $0.25

RPTX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (15.3% over 20 days), RSI 73

RSI (14): 73.3 · Price: $2.65

Fundamentals Snapshot

Metric MDCX RPTX
Market Cap
Forward P/E -0.7 -3.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.8%
Gross Margin 4.0%
Operating Margin 0.0% 0.0%
EPS -2.36 -1.70
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MDCX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.